Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kjersti Flatmark

Showing results (71-80 of 133) with videos related to

Pageof 14
Sort By:
Molecular Cancer|April 29, 2008
Principal component analysis for the comparison of metabolic profiles from human rectal cancer biopsies and colorectal xenografts using high-resolution magic angle spinning 1H magnetic resonance spectroscopyTherese Seierstad, Kathrine Røe, Beathe Sitter, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 20, 2025
Peritoneal Surface Oncology surgery: Reflections on key determinants of success for female surgeons in this challenging disciplineBeate Rau, Aditi Bhatt, Lana Bijelic, et al.
Translational Oncology|May 31, 2019
Circulating Exosomal miR-141-3p and miR-375 in Metastatic Progression of Rectal CancerSebastian Meltzer, Tonje Bjørnetrø, Lars Gustav Lyckander, et al.
Plos One|March 4, 2014
Biomarkers of histone deacetylase inhibitor activity in a phase 1 combined-modality study with radiotherapyAnne Hansen Ree, Marie Grøn Saelen, Erta Kalanxhi, et al.
Cancer Immunology, Immunotherapy : CII|January 2, 2020
Immunogenic cell death by neoadjuvant oxaliplatin and radiation protects against metastatic failure in high-risk rectal cancerSimer J Bains, Hanna Abrahamsson, Kjersti Flatmark, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 1, 2019
ImmunoPeCa trial: Long-term outcome following intraperitoneal MOC31PE immunotoxin treatment in colorectal peritoneal metastasisIda S Frøysnes, Yvonne Andersson, Stein G Larsen, et al.
International Journal of Cancer|March 16, 2013
Immunotoxin targeting EpCAM effectively inhibits peritoneal tumor growth in experimental models of mucinous peritoneal surface malignanciesKjersti Flatmark, Ingrid J Guldvik, Hege Svensson, et al.
Annals of Surgical Oncology|March 3, 2018
Vertical Rectus Abdominis Musculocutaneous Flap Repair Improves Perineal Wound Healing after Abdominoperineal Resection for Irradiated Locally Advanced Rectal CancerMilan Spasojevic, Anthony B Mariathasan, Mariusz Goscinski, et al.
Plos One|December 11, 2012
Tumor phosphatidylinositol-3-kinase signaling and development of metastatic disease in locally advanced rectal cancerAnne Hansen Ree, Annette Torgunrud Kristensen, Marie Grøn Saelen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 27, 2015
High tumor glycine concentration is an adverse prognostic factor in locally advanced rectal cancerKathrine Røe Redalen, Beathe Sitter, Tone Frost Bathen, et al.
Pageof 14

Showing results (71-80 of 133) with videos related to

Sort By:
Pageof 14
Molecular Cancer|April 29, 2008
Principal component analysis for the comparison of metabolic profiles from human rectal cancer biopsies and colorectal xenografts using high-resolution magic angle spinning 1H magnetic resonance spectroscopyTherese Seierstad, Kathrine Røe, Beathe Sitter, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 20, 2025
Peritoneal Surface Oncology surgery: Reflections on key determinants of success for female surgeons in this challenging disciplineBeate Rau, Aditi Bhatt, Lana Bijelic, et al.
Translational Oncology|May 31, 2019
Circulating Exosomal miR-141-3p and miR-375 in Metastatic Progression of Rectal CancerSebastian Meltzer, Tonje Bjørnetrø, Lars Gustav Lyckander, et al.
Plos One|March 4, 2014
Biomarkers of histone deacetylase inhibitor activity in a phase 1 combined-modality study with radiotherapyAnne Hansen Ree, Marie Grøn Saelen, Erta Kalanxhi, et al.
Cancer Immunology, Immunotherapy : CII|January 2, 2020
Immunogenic cell death by neoadjuvant oxaliplatin and radiation protects against metastatic failure in high-risk rectal cancerSimer J Bains, Hanna Abrahamsson, Kjersti Flatmark, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 1, 2019
ImmunoPeCa trial: Long-term outcome following intraperitoneal MOC31PE immunotoxin treatment in colorectal peritoneal metastasisIda S Frøysnes, Yvonne Andersson, Stein G Larsen, et al.
International Journal of Cancer|March 16, 2013
Immunotoxin targeting EpCAM effectively inhibits peritoneal tumor growth in experimental models of mucinous peritoneal surface malignanciesKjersti Flatmark, Ingrid J Guldvik, Hege Svensson, et al.
Annals of Surgical Oncology|March 3, 2018
Vertical Rectus Abdominis Musculocutaneous Flap Repair Improves Perineal Wound Healing after Abdominoperineal Resection for Irradiated Locally Advanced Rectal CancerMilan Spasojevic, Anthony B Mariathasan, Mariusz Goscinski, et al.
Plos One|December 11, 2012
Tumor phosphatidylinositol-3-kinase signaling and development of metastatic disease in locally advanced rectal cancerAnne Hansen Ree, Annette Torgunrud Kristensen, Marie Grøn Saelen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 27, 2015
High tumor glycine concentration is an adverse prognostic factor in locally advanced rectal cancerKathrine Røe Redalen, Beathe Sitter, Tone Frost Bathen, et al.
Pageof 14